VP & GM, Global Generics
November 13, 2019
At West, we work by the side of our generic drug partners to ensure that they have access to components that not only meet the increasing demand for better quality packaging and delivery for generic drug products, but also provide the efficiencies they need to make the move to market fast.
Speed to market is also important for generic customers who may hold a number of Abbreviated New Drug Applications (ANDAs ) and need to move quickly to produce different products in their portfolio, which can be driven by market conditions such as drug shortages where there is a need to respond immediately.
Our AccelTRA® component program provides a robust, efficient platform of components that are compatible with a broad variety of generics molecules and chemicals. This program offers customers the possibility of building a platform of delivery options and packaging for a variety of molecules with a single supply platform.
In addition, West has built a global supply chain network to provide made-to-stock AccelTRA components with extremely fast sampling and delivery lead times. Samples are available with a one-week lead time, and commercial quantities within six weeks.
At West, we’re by your side with excellent technical service that helps customers work through issues and make the move to market fast. We bring the service solutions – including laboratory services, contract manufacturing, and regulatory support for a growing number of proprietary delivery devices – so that customers that need to move fast have the services available to help. Click the links for more information about our AccelTRA program, or our Integrated Solutions (link) program.
AccelTRA® is a registered trademark of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.